Skip to main content
. 2020 Apr 27;11(15):4352–4365. doi: 10.7150/jca.44436

Table 1.

Clinical characteristics of included patients with gastric cancer

Characteristics Total Training dataset (n=268) Testing dataset (n=114)
Sex
Female 136(35.6) 97(36.19) 39(34.21)
Male 246(64.4) 171(63.81) 75(65.79)
Histological type
Stomach Adenocarcinoma 204(53.4) 139(51.9) 65(57.0)
Stomach- Intestinal Adenocarcinoma 177(46.3) 128(47.8) 49(43.0)
Other 1(0.26) 1(0.37)
Stage
Stage I 50(13.1) 30(11.2) 20(17.6)
Stage II 127(33.2) 94(35.1) 33(28.9)
Stage III 172(45.0) 121(45.1) 51(44.7)
Stage IV 33(8.64) 23(8.58) 10(8.77)
Metastasis status
M0 344(90.05) 243(90.67) 101(88.6)
M1 22(5.76) 13(4.85) 9(7.89)
MX 16(4.19) 12(4.48) 4(3.51)
Age
<=65 178(46.6) 120(44.78) 58(50.88)
>65 201(52.62) 145(54.1) 56(49.12)
NA 3(0.79) 3(1.12)
Anatomic sites
Antrum/Distal 141(36.91) 104(38.81) 37(32.46)
Cardia/Proximal 52(13.61) 34(12.69) 18(15.79)
Fundus/Body 142(37.17) 101(37.69) 41(35.96)
Gastroesophageal Junction 38(9.95) 20(7.46) 18(15.79)
Other 9(2.3) 9(3.3)